首页> 外文期刊>The Analyst: The Analytical Journal of the Royal Society of Chemistry: A Monthly International Publication Dealing with All Branches of Analytical Chemistry >Detection of cardiovascular disease associated miR-29a using paper-based microfluidics and surface enhanced Raman scattering
【24h】

Detection of cardiovascular disease associated miR-29a using paper-based microfluidics and surface enhanced Raman scattering

机译:使用纸质微流体和表面增强拉曼散射检测心血管疾病相关的miR-29a相关的miR-29a

获取原文
获取原文并翻译 | 示例
       

摘要

The development of viable point-of-care diagnostic formats is integral to achieving better patient care and improved outcomes. The need for robust and low-cost tests is especially important in underresourced and rural settings. Perhaps the greatest challenge is ensuring that an untrained individual is capable of operating and interpreting the test, out with a care facility. Here we present a paper-based diagnostic device capable of sensing miR-29a using both colorimetric and surface enhanced Raman scattering (SERS) analysis. Rather, than carry out the two types of analyses in tandem, we envisage that the colorimetric output is easy enough to be interpreted by the untrained-individual administering the test to provide them with qualitative feedback. If deemed positive, the test can be further validated at a centralized care facility using a handheld-Raman spectrometer to provide a semi-quantitative result. Detection of miR-29a, a microRNA associated with myocardial infarction, was achieved at a level of pg μL~(-1) through the combination of three-dimensional paper-based microfluidics, colorimetric detection, and surface enhanced Raman scattering (SERS) analysis. RGB analysis of the colorimetric output generated from samples containing miR-29a at different concentrations (18-360 pg μL~(-1)) showed differentiation from the control sample, however significant repeat variability indicated that it could not be used for quantifying miR-29a levels. However, the SERS analysis exhibited greater reproducibility at varying concentrations, achieving an LoD of 47 pg μL~(-1). The union of the paper-based device and the two analysis methods resulted in the production of a sensitive, reproducible and facile, point of care test (POCT), which paves the way for future implementation in the diagnosis of a range of diseases.
机译:可行的护理点诊断格式的发展是实现更好的患者护理和改进的结果的一体化。在欠款和农村环境中,对强大和低成本测试的需求尤为重要。也许最大的挑战是确保未经训练的人能够使用护理设施来运营和解释测试。在这里,我们介绍了一种基于纸质诊断装置,其能够使用比色和表面增强的拉曼散射(SERS)分析来感测MIR-29A。相反,对于串联进行两种类型的分析,我们设想了比色输出容易被未经许地管理测试来解释,以便为它们提供定性反馈。如果被认为是阳性的,可以使用手扶拉曼光谱仪在集中护理设施中进一步验证测试,以提供半定量结果。通过三维纸基微流体,比色性检测和表面增强拉曼散射(SERS)分析,在PGμL〜(-1)的水平下检测MiR-29a,与心肌梗死相关的微小RORNA。 。 RGB分析从不同浓度的含有miR-29a的样品产生的比色输出(18-360pgμl〜(-1))显示出与对照样品的分化,然而,显着的重复变化表明它不能用于量化mir- 29A级别。然而,SERS分析以不同的浓度表现出更高的再现性,实现47pgμl〜(-1)的床位。纸型器件和两种分析方法的联盟导致生产敏感,可重复和轻巧,护理点(POCT),为未来实施的诊断造成了一系列疾病的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号